| SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice J Pollet, WH Chen, L Versteeg, B Keegan, B Zhan, J Wei, Z Liu, J Lee, ... Human vaccines & immunotherapeutics 17 (8), 2356-2366, 2021 | 90 | 2021 |
| Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate WH Chen, J Wei, RT Kundu, R Adhikari, Z Liu, J Lee, L Versteeg, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1865 (6), 129893, 2021 | 53 | 2021 |
| Prevalence of intestinal parasites in a low-income Texas community R Singer, TH Xu, LNS Herrera, MJ Villar, KM Faust, PJ Hotez, ARA Aiken, ... The American journal of tropical medicine and hygiene 102 (6), 1386, 2020 | 34 | 2020 |
| Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate WH Chen, J Pollet, U Strych, J Lee, Z Liu, RT Kundu, L Versteeg, MJ Villar, ... Protein Expression and Purification 190, 106003, 2022 | 30 | 2022 |
| Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern J Pollet, U Strych, WH Chen, L Versteeg, B Keegan, B Zhan, J Wei, Z Liu, ... Vaccine 40 (26), 3655-3663, 2022 | 25 | 2022 |
| Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection JV Cruz-Chan, LE Villanueva-Lizama, L Versteeg, A Damania, MJ Villar, ... Scientific reports 11 (1), 3222, 2021 | 21 | 2021 |
| Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi L Versteeg, R Adhikari, C Poveda, MJ Villar-Mondragon, KM Jones, ... PLoS Neglected Tropical Diseases 15 (9), e0009689, 2021 | 11 | 2021 |
| Elevated pediatric Chagas disease burden complicated by concomitant intestinal parasites and malnutrition in El Salvador MS Nolan, KO Murray, R Mejia, PJ Hotez, MJ Villar Mondragon, ... Tropical Medicine and Infectious Disease 6 (2), 72, 2021 | 10 | 2021 |
| From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access PJ Hotez, R Adhikari, WH Chen, YL Chen, P Gillespie, NY Islam, ... Expert Review of Vaccines 22 (1), 495-500, 2023 | 9 | 2023 |
| Signal transducer and activator of transcription-3 modulation of cardiac pathology in chronic chagasic cardiomyopathy KA Hoffman, MJ Villar, C Poveda, ME Bottazzi, PJ Hotez, DJ Tweardy, ... Frontiers in Cellular and Infection Microbiology 11, 708325, 2021 | 9 | 2021 |
| Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease C Mancino, J Pollet, A Zinger, KM Jones, MJ Villar, AC Leao, R Adhikari, ... ACS Applied Materials & Interfaces 16 (13), 15832-15846, 2024 | | 2024 |
| Receptor-binding domain recombinant protein RBD219-N1C1 on alum-CpG induces broad protection against SARS-CoV-2 variants of concern J Pollet, U Strych, WH Chen, L Versteeg, B Keegan, B Zhan, J Wei, Z Liu, ... bioRxiv, 2021 | | 2021 |
| ENVIRONMENTAL CONTAMINATION WITH INTESTINAL PARASITES IN THE SOUTHERN USA CC Blackburn, M Lively, C Flowers, NL Herrera, MJV Mondragon, R Mejia AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 101, 581-581, 2019 | | 2019 |
